HLB Therapeutics Co.,Ltd.
115450
Rank in Stocks
#18658
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Share Price
$1.89
Market Cap
$178.56M
Change (1 day)
0.00%
Change (1 year)
-5.48%
Country
KR
Trade HLB Therapeutics Co.,Ltd. (115450)
Category
Healthcare
Market Capitalization of HLB Therapeutics Co.,Ltd.(115450)
Market Cap: $178.56M
As of October 2026 HLB Therapeutics Co.,Ltd. has a market cap of $178.56M. This makes HLB Therapeutics Co.,Ltd. the world's 18658th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of HLB Therapeutics Co.,Ltd. from 2010 to 2026
115450 compared with Top 5 Most Popular stocks
